30.06
                                            
                                Panoramica
                                Notizia
                                Cronologia dei prezzi
                                    Catena di opzioni
                                Financials
                                    Perché ALKS Giù?
                                Forum
                                Previsione
                                    Frazionamento azionario
                        
                        Precedente Chiudi:
              $30.70
            Aprire:
              $30
            Volume 24 ore:
                19,883
            Relative Volume:
              0.01
            Capitalizzazione di mercato:
                $4.96B
            Reddito:
              $1.51B
            Utile/perdita netta:
              $333.35M
            Rapporto P/E:
              15.42
            EPS:
                1.95
            Flusso di cassa netto:
                $315.22M
            1 W Prestazione:
              +1.51%
            1M Prestazione:
              -2.87%
            6M Prestazione:
                -5.07%
            1 anno Prestazione:
              +13.98%
            Alkermes Plc Stock (ALKS) Company Profile
Nome
                  
                      Alkermes Plc
                    
                Settore
                  Telefono
                  
                      00-353-1-772-8000
                    
                Indirizzo
                  
                      CONNAUGHT HOUSE, DUBLIN 4
                    
                Confronta ALKS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ALKS
                            
                             
                        Alkermes Plc 
                           | 
                    30.04 | 5.07B | 1.51B | 333.35M | 315.22M | 1.95 | 
| 
                         
                          
                                ZTS
                            
                             
                        Zoetis Inc 
                           | 
                    123.50 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 | 
| 
                         
                          
                                TAK
                            
                             
                        Takeda Pharmaceutical Co Adr 
                           | 
                    13.55 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 | 
| 
                         
                          
                                HLN
                            
                             
                        Haleon Plc Adr 
                           | 
                    9.27 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 | 
| 
                         
                          
                                TEVA
                            
                             
                        Teva Pharmaceutical Industries Ltd Adr 
                           | 
                    20.23 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 | 
| 
                         
                          
                                UTHR
                            
                             
                        United Therapeutics Corp 
                           | 
                    433.65 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 | 
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2025-09-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform | 
| 2025-09-03 | Iniziato | Wells Fargo | Overweight | 
| 2025-07-15 | Iniziato | Goldman | Buy | 
| 2025-06-17 | Aggiornamento | UBS | Neutral → Buy | 
| 2025-05-28 | Iniziato | Needham | Buy | 
| 2025-03-13 | Iniziato | RBC Capital Mkts | Sector Perform | 
| 2025-03-04 | Aggiornamento | UBS | Sell → Neutral | 
| 2025-02-11 | Iniziato | Deutsche Bank | Buy | 
| 2024-11-05 | Aggiornamento | Stifel | Hold → Buy | 
| 2024-06-17 | Iniziato | TD Cowen | Buy | 
| 2024-03-19 | Iniziato | Robert W. Baird | Outperform | 
| 2024-02-20 | Downgrade | UBS | Neutral → Sell | 
| 2023-11-20 | Ripresa | JP Morgan | Neutral | 
| 2023-10-24 | Aggiornamento | Evercore ISI | In-line → Outperform | 
| 2023-10-17 | Iniziato | UBS | Neutral | 
| 2022-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight | 
| 2022-10-14 | Aggiornamento | BofA Securities | Underperform → Neutral | 
| 2022-08-16 | Iniziato | Piper Sandler | Neutral | 
| 2022-04-22 | Ripresa | Goldman | Buy | 
| 2022-04-20 | Iniziato | Goldman | Buy | 
| 2022-01-27 | Aggiornamento | Cantor Fitzgerald | Hold → Overweight | 
| 2021-12-01 | Iniziato | Citigroup | Neutral | 
| 2021-10-07 | Aggiornamento | Jefferies | Hold → Buy | 
| 2021-09-02 | Downgrade | BofA Securities | Neutral → Underperform | 
| 2020-10-15 | Aggiornamento | Mizuho | Neutral → Buy | 
| 2020-07-30 | Downgrade | Goldman | Neutral → Sell | 
| 2020-02-14 | Downgrade | BofA/Merrill | Buy → Neutral | 
| 2020-02-14 | Reiterato | H.C. Wainwright | Neutral | 
| 2020-02-14 | Downgrade | JP Morgan | Overweight → Neutral | 
| 2020-02-06 | Iniziato | Mizuho | Neutral | 
| 2020-01-31 | Aggiornamento | Wolfe Research | Underperform → Peer Perform | 
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight | 
| 2019-07-15 | Aggiornamento | Goldman | Sell → Neutral | 
| 2019-05-31 | Iniziato | H.C. Wainwright | Neutral | 
| 2019-05-01 | Downgrade | Citigroup | Buy → Neutral | 
| 2018-12-19 | Downgrade | Goldman | Neutral → Sell | 
| 2018-12-14 | Iniziato | Wolfe Research | Underperform | 
| 2018-12-13 | Downgrade | Credit Suisse | Outperform → Underperform | 
| 2018-11-05 | Iniziato | Piper Jaffray | Neutral | 
| 2018-08-07 | Iniziato | Stifel | Hold | 
| 2018-06-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight | 
| 2018-06-06 | Iniziato | B. Riley FBR, Inc. | Buy | 
| 2018-05-16 | Aggiornamento | Citigroup | Neutral → Buy | 
| 2018-05-11 | Iniziato | BofA/Merrill | Buy | 
                    Mostra tutto
                    
                  
                Alkermes Plc Borsa (ALKS) Ultime notizie
Hussman Strategic Advisors Inc. Acquires New Holdings in Alkermes plc $ALKS - MarketBeat
Can Alkermes plc stock deliver consistent earnings growthJuly 2025 Highlights & Verified Short-Term Plans - newser.com
Applying Elliott Wave Theory to Alkermes plcJuly 2025 Patterns & Reliable Volume Spike Alerts - newser.com
Can Alkermes plc stock maintain growth trajectoryJuly 2025 Opening Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
Risk vs reward if holding onto Alkermes plcJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
How Alkermes plc (8AK) stock valuation compares with sector2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Why Alkermes plc stock is seen as undervaluedQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
What moving averages say about Alkermes plcQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Is Alkermes plc (8AK) stock at risk of policy regulationGold Moves & Weekly Chart Analysis and Guides - newser.com
Relative strength of Alkermes plc in sector analysisJuly 2025 Drop Watch & AI Powered Market Entry Strategies - newser.com
How resilient is Alkermes plc stock in market downturnsOptions Play & Expert-Curated Trade Recommendations - newser.com
Is Alkermes plc forming a bottoming base2025 Technical Overview & Stock Timing and Entry Methods - newser.com
Is Alkermes plc (8AK) stock a safe buy pre earningsCEO Change & Weekly Watchlist for Hot Stocks - newser.com
Price momentum metrics for Alkermes plc explainedTrade Risk Summary & Technical Buy Zone Confirmations - newser.com
What to do if you’re stuck in Alkermes plc2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Why Alkermes plc stock appeals to analysts2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - newser.com
What recovery options are there for Alkermes plc2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Applying Wyckoff theory to Alkermes plc stockMarket Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Exit strategy if you’re trapped in Alkermes plcJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Jennison Associates LLC Buys New Position in Alkermes plc $ALKS - MarketBeat
State of New Jersey Common Pension Fund D Boosts Stock Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Alkermes (NASDAQ:ALKS) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Moody Aldrich Partners LLC Has $1.92 Million Stock Position in Alkermes plc $ALKS - MarketBeat
Order flow analysis tools used on Alkermes plcMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Alkermes plc Just Recorded A 62% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Real time social sentiment graph for Alkermes plcBuy Signal & Free Accurate Trade Setup Notifications - newser.com
Alkermes Plc Azioni (ALKS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):